RYLIGENCY 20 mg/ml, solution for injection in a pre-filled syringe 10 syringes of 5 ml
Active ingredients: Lidocaine hydrochloride, Lidocaine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 syringes of 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RYLIGENCY 20 mg/mL, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 10 seringues préremplies graduées en polypropylène de 5 mL
- Marketing authorisation holder
- AGUETTANT
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 Feb 2021
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- For professional use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68563133CIP73016068CIP133400930160688Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LIDOCAÏNE (CHLORHYDRATE DE) MONOHYDRATÉsolution | — | SA |
| CHLORHYDRATE DE LIDOCAÏNE ANHYDREsolution | 20,0 mg · 1 mL de solution injectable | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.